Literature DB >> 9692375

Medicinal marijuana: a comprehensive review.

R J Gurley1, R Aranow, M Katz.   

Abstract

Considerable controversy exists regarding the role of marijuana as a therapeutic agent; however, many practitioners are taught very little about existing marijuana data. The authors therefore undertook a comprehensive literature review of the topic. References were identified using textbooks, review and opinion articles, and a primary literature review in MEDLINE. Sources were included in this review based primarily on the quality of the data. Some data exists that lends credence to many of the claims about marijuana's properties. In general, however, the body of literature about marijuana is extremely poor in quality. Marijuana and/or its components may help alleviate suffering in patients with a variety of serious illnesses. Health care providers can best minimize short term adverse consequences and drug interactions for terminally ill patients by having a thorough understanding of the pharmacology of marijuana, potential adverse reactions, infection risks, and drug interactions (along with on-going monitoring of the patient). For chronic conditions, the significance and risk of short and long term adverse effects must be weighed against the desired benefit. Patients who are best suited to medicinal marijuana will be those who will gain substantial benefit to offset these risks, and who have failed a well-documented, compliant and comprehensive approach to standard therapies.

Entities:  

Mesh:

Year:  1998        PMID: 9692375     DOI: 10.1080/02791072.1998.10399683

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  9 in total

Review 1.  Neuropsychiatric effects of prescription drug abuse.

Authors:  Jason P Caplan; Lucy A Epstein; Davin K Quinn; Jonathan R Stevens; Theodore A Stern
Journal:  Neuropsychol Rev       Date:  2007-08-16       Impact factor: 7.444

Review 2.  Cannabinoids in clinical practice.

Authors:  E M Williamson; F J Evans
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 3.  Assessing marijuana use in bariatric surgery candidates: should it be a contraindication?

Authors:  Christina M Rummell; Leslie J Heinberg
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

Review 4.  Plant-Derived and Endogenous Cannabinoids in Epilepsy.

Authors:  Alberto Verrotti; Miriam Castagnino; Mauro Maccarrone; Filomena Fezza
Journal:  Clin Drug Investig       Date:  2016-05       Impact factor: 2.859

5.  The Treatment of Obesity and Its Co-occurrence with Substance Use Disorders.

Authors:  Katherine A Vanbuskirk; Marc N Potenza
Journal:  J Addict Med       Date:  2010-03       Impact factor: 3.702

6.  Illicit drug use and prescription drug misuse among young adult medical cannabis patients and non-patient users in Los Angeles.

Authors:  Ekaterina V Fedorova; Sheree M Schrager; Lucy F Robinson; Alice Cepeda; Carolyn F Wong; Ellen Iverson; Stephen E Lankenau
Journal:  Drug Alcohol Depend       Date:  2019-02-27       Impact factor: 4.492

7.  Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation.

Authors:  Tzu-Tang Wei; Mark Chandy; Masataka Nishiga; Angela Zhang; Kaavya Krishna Kumar; Dilip Thomas; Amit Manhas; Siyeon Rhee; Johanne Marie Justesen; Ian Y Chen; Hung-Ta Wo; Saereh Khanamiri; Johnson Y Yang; Frederick J Seidl; Noah Z Burns; Chun Liu; Nazish Sayed; Jiun-Jie Shie; Chih-Fan Yeh; Kai-Chien Yang; Edward Lau; Kara L Lynch; Manuel Rivas; Brian K Kobilka; Joseph C Wu
Journal:  Cell       Date:  2022-04-29       Impact factor: 66.850

8.  Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.

Authors:  Eric P Baron; Philippe Lucas; Joshua Eades; Olivia Hogue
Journal:  J Headache Pain       Date:  2018-05-24       Impact factor: 7.277

Review 9.  Medical cannabis and cannabidiol: A new harvest for Malawi.

Authors:  Gama Bandawe
Journal:  Malawi Med J       Date:  2022-06       Impact factor: 1.413

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.